Does the nonsense‐mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?
暂无分享,去创建一个
Olga Anczuków | D. Stoppa-Lyonnet | O. Sinilnikova | S. Mazoyer | M. Buisson | M. Ware | A. B. Zetoune
[1] Olga Anczuków,et al. The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon , 2006, Human mutation.
[2] H. Nevanlinna,et al. The CHEK2 gene and inherited breast cancer susceptibility , 2006, Oncogene.
[3] R. Eeles,et al. Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation. , 2006, Cancer research.
[4] D. Dickson,et al. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD) , 2006, Neurobiology of Disease.
[5] J. Lupski,et al. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease , 2006, European Journal of Human Genetics.
[6] B. Bembi,et al. Identification of nine new IDS alleles in mucopolysaccharidosis II. Quantitative evaluation by real-time RT-PCR of mRNAs sensitive to nonsense-mediated and nonstop decay mechanisms. , 2006, Biochimica et biophysica acta.
[7] Y. Kajiwara,et al. Monoallelic BUB1B mutations and defective mitotic‐spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome , 2006, American journal of medical genetics. Part A.
[8] S. Tavtigian,et al. Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene? , 2006, Oncogene.
[9] Sikandar G. Khan,et al. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. , 2006, Carcinogenesis.
[10] David P Lane,et al. p53 isoforms can regulate p53 transcriptional activity. , 2005, Genes & development.
[11] S. Ellard,et al. The position of premature termination codons in the hepatocyte nuclear factor −1 beta gene determines susceptibility to nonsense-mediated decay , 2005, Human Genetics.
[12] E. Conti,et al. Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species. , 2005, Current opinion in cell biology.
[13] M. Gonzalès,et al. Expression of mutant JAGGED1 alleles in patients with Alagille syndrome , 2005, Human Genetics.
[14] A. Spurdle,et al. Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals , 2005, British Journal of Cancer.
[15] S. Geisler,et al. Alternative splicing and mutation status of CHEK2 in stage III breast cancer , 2004, Oncogene.
[16] Francisco Martinez-Murillo,et al. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise , 2004, Nature Genetics.
[17] A. Choudhury,et al. Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression* , 2004, Journal of Biological Chemistry.
[18] Nazneen Rahman,et al. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. , 2004, American journal of human genetics.
[19] T. Ohnishi,et al. Inhibition of nonsense‐mediated mRNA decay rescues the phenotype in Ullrich's disease , 2004, Annals of neurology.
[20] D. Stoppa-Lyonnet,et al. Analysis of the allele‐specific expression of the mismatch repair gene MLH1 using a simple DHPLC‐Based Method , 2004, Human mutation.
[21] J. Lupski,et al. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations , 2004, Nature Genetics.
[22] S. Brenner,et al. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. Bertini,et al. Effects on Collagen VI mRNA Stability and Microfibrillar Assembly of Three COL6A2 Mutations in Two Families with Ullrich Congenital Muscular Dystrophy* , 2002, The Journal of Biological Chemistry.
[24] D. Stoppa-Lyonnet,et al. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. , 2002, Human molecular genetics.
[25] J. Mendell,et al. Separable Roles for rent1/hUpf1 in Altered Splicing and Decay of Nonsense Transcripts , 2002, Science.
[26] Y. Taya,et al. Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. , 2001, Genes & development.
[27] Jing Chen,et al. Characterization of Tumor-associated Chk2 Mutations* , 2001, The Journal of Biological Chemistry.
[28] L. Neckers,et al. Regulation of BRCA1 by protein degradation , 1999, Oncogene.
[29] M. Hentze,et al. Binary specification of nonsense codons by splicing and cytoplasmic translation , 1998, The EMBO journal.
[30] Yonghong Xiao,et al. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.
[31] A Estreicher,et al. The human tumour suppressor gene p53 is alternatively spliced in normal cells. , 1996, Oncogene.
[32] S. Schraub,et al. Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations. , 1994, Oncogene.